Treatment of Epididymitis
For sexually active men under 35 years, treat with ceftriaxone 1g IM/IV single dose PLUS doxycycline 100mg twice daily for 7 days; for men over 35 years or those with enteric pathogen risk, use levofloxacin 500mg daily or ofloxacin 200mg twice daily for 7-10 days. 1
Age-Based Treatment Algorithm
The treatment approach fundamentally depends on the patient's age and sexual activity, as this determines the most likely causative organism:
Men <35 Years (Sexually Active)
The primary pathogens are Chlamydia trachomatis and Neisseria gonorrhoeae 1, 2. However, recent molecular diagnostic studies show STIs are not strictly limited to this age group and can occur in older men as well 3.
Recommended regimen:
- Ceftriaxone 1g IM or IV single dose
- PLUS Doxycycline 100mg orally twice daily for 7 days 1
This dual therapy is critical because ciprofloxacin, while historically popular, is inadequate for treating chlamydial infections and should be avoided as monotherapy in this population 4. The 2024 EAU guidelines explicitly recommend this combination, reflecting the high rates of quinolone-resistant gonorrhea 1.
Men Who Practice Insertive Anal Intercourse
These patients require coverage for enteric organisms in addition to STIs 2.
Recommended regimen:
- Ceftriaxone 1g IM/IV single dose
- PLUS Levofloxacin 500mg daily for 10 days (or ofloxacin 200mg twice daily) 2
Men >35 Years or With Bladder Outlet Obstruction
The predominant pathogens are Enterobacterales (especially E. coli), typically from urinary reflux into the ejaculatory ducts 1, 2, 3.
Recommended regimen:
- Levofloxacin 500mg orally once daily for 7-10 days 1, 2
- OR Ofloxacin 200mg orally twice daily for 7-10 days 1
Fluoroquinolones remain highly effective in this population, with >85% susceptibility rates in antibiotic-naive patients 3.
Key Diagnostic Considerations
Obtain urethral swab or first-void urine for:
- Gonorrhea and chlamydia testing (NAAT preferred)
- Gram stain for intracellular diplococci
- Culture when available 1, 3
Scrotal ultrasound establishes the diagnosis and differentiates from testicular torsion 5. Note that normal urinalysis does not exclude epididymitis 5.
Modern molecular diagnostics (16S rDNA analysis, PCR) identify causative pathogens in up to 88% of antibiotic-naive cases, predominantly E. coli (56%), with STIs accounting for 14% across all age groups 3.
Treatment Duration and Follow-Up
- Duration: 7-10 days for most cases 1, 2
- Studies show average treatment duration of 11 days in naive patients and 13 days in pretreated patients 3
- Sexual abstinence: 7 days after single-dose therapy or until completion of 7-day regimen 6
- Partner treatment: All sexual partners within preceding 60 days require evaluation and empiric chlamydia treatment 6
Common Pitfalls to Avoid
- Do NOT use ciprofloxacin monotherapy in young sexually active men - it lacks adequate chlamydial coverage 4
- Do NOT assume STIs only occur in men <35 - molecular studies show they occur across age groups 3
- Do NOT skip partner notification - this is essential to prevent reinfection 6
- Refer to genitourinary medicine clinic for contact tracing, especially in STI cases 4
Recurrent or Persistent Cases
If symptoms persist after appropriate treatment with documented compliance and no re-exposure:
- Consider Mycoplasma genitalium (treat with azithromycin 500mg day 1, then 250mg for 4 days, or moxifloxacin 400mg daily for 7-14 days if macrolide-resistant) 1
- Consider Trichomonas vaginalis (treat with metronidazole 2g single dose) 1
- Evaluate for Ureaplasma urealyticum (doxycycline-resistant strains exist) 6
The evidence strongly supports that viral epididymitis is rare (only 1% in comprehensive studies), so empirical antibacterial therapy remains appropriate 3.